Merck, Verona Pharma saw HSR waiting period expire on Sept. 4
MLex Summary: Merck and Verona Pharma saw the Hart-Scott-Rodino Act waiting period for their transaction expire on September 4, 2025, according to a securities filing. The companies filed their premerger notification...To view the full article, register now.
Already a subscriber? Click here to view full article